On the other hand, CD38 is mainly regarded as the biomarker of the Plasma Blast-Plasma cell, particularly highly and uniformly expressed in Multiple Myeloma, a cancer characterized by proliferation of malignant plasma cells in the bone marrow. The gene discussed is CD38; the disease is cancer.